Malaguarnera, M., Vacante, M., Giordano, M., Motta, M., Bertino, G., Pennisi, M., Neri, S., Malaguarnera, M., Li, Volti G., and Galvano, F
A review in the theme: cell and molecular processes in cancer metastasis
Ne jamais doubler une dose en cas doubli
In a separate study, test subjects increased their bench press strength by an amazing 18.6% in just 10 days
Collectively, our findings demonstrate that eGFR, irrespective of disease stage, is the primary modifiable modulator of circulating TMAO, which then by promoting renal fibrosis in conjunction with established pathophysiology (second-hit model) further negatively impacts kidney function
For secondary TMAU driven by gut dysbiosis, microbiome intervention is a logical target